# To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

> **NCT03445338** · PHASE1 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** K0706
- **DRUG:** K0706
- **DRUG:** K0706

## Key facts

- **NCT ID:** NCT03445338
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-15
- **Primary completion:** 2019-12-06
- **Final completion:** 2019-12-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03445338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03445338, "To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03445338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*